(lp0
S'Price Alert: Verastem Inc  Stock Nears Resistance -- Technicals ... CML News - 12 hours ago Price Alert: Verastem Inc  has now crossed into technical strength -- watch the technical oscillators for momentum gaps.'
p1
aS'10 hedge funds buy Verastem, Inc.  for the first time Post Analyst - 20 hours ago Verastem, Inc.  reached 42.86% versus a 1-year low price of $1.05. The stock was last seen 2.74% higher, reaching at $1.5 on Mar. 17, 2017.Will Verastem, Inc.  be growing after Earnings Report? - FactsReporterTrader Alert: Unusual Volume Spotted in Verastem, Inc.  - Melville Review'
p2
aS'Verastem shares plunge as drug trial fails The Boston Globe - Sep 28, 2015 Shares of Verastem Inc. plummeted 67.4 percent Monday after the Cambridge biotech reported that its lead drug candidate failed to help patients suffering from a rare form of lung cancer.Verastem stops cancer therapy development; shares plunge - ReutersVerastem Stops Enrollment Due to Futility in the COMMAND Study of VS-6063 for ... - Business Wire '
p3
aS"Stock Update on Earnings &amp; Estimates for Verastem, Inc.  Aiken Advocate - 16 hours ago Investors and analysts will be looking ahead to Verastem, Inc. 's next earnings report which is slated to be released sometime on or around 2017-03-23 for the period ending on 2016-12-31."
p4
aS'Verastem to Present at the Oppenheimer 27th Annual Healthcare Conference Yahoo Finance - Mar 15, 2017 Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21st at 2:10 p.m. ET at the Westin Grand&nbsp;...'
p5
aS"Stock On the Run: Verastem, Inc.  HugoPress - Mar 14, 2017 Jefferies Maintains Verastem, Inc. 's stock to Hold with the price target of $1.5. This rating was issued on 8/09/16.Earnings Clues on Innoviva, Inc. , Verastem, Inc.  Analyst's ... - StockNewsJournalStocks in the Spotlight: Verastem, Inc.  , Nuveen Dividend ... - NYSE Journal "
p6
aS'Verastem Names Gregory I. Berk, MD as Chief Medical Officer Business Wire  - Apr 18, 2016 BOSTON----Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced the appointment of Gregory I. Berk, MD as Chief Medical Officer.'
p7
aS'Verastem, Inc.  held by 17 SEC 13F Filers Post Analyst - Mar 15, 2017 Verastem, Inc.  reached 30.48% versus a 1-year low price of $1.05. The stock was last seen -11.04% lower, reaching at $1.37 on Mar. 14, 2017.Should You Buy Or Sell Verastem, Inc.  On Analyst Concensus? - NewsDen'
p8
aS'Verastem to Present at the 29th Annual ROTH Conference Yahoo Finance - Mar 7, 2017 Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 29th Annual ROTH Conference on Monday, March 13th at 4:00 p.m. PT at the Ritz Carlton in Dana Point, CA.'
p9
aS'Verastem Announces the Presentation of Clinical Data at iMig 2016 Business Wire  - May 3, 2016 BOSTON----Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced the presentation of clinical data by Professor Raphael Bueno, M.D.'
p10
a.